JP2022506944A5 - - Google Patents
Info
- Publication number
- JP2022506944A5 JP2022506944A5 JP2021525096A JP2021525096A JP2022506944A5 JP 2022506944 A5 JP2022506944 A5 JP 2022506944A5 JP 2021525096 A JP2021525096 A JP 2021525096A JP 2021525096 A JP2021525096 A JP 2021525096A JP 2022506944 A5 JP2022506944 A5 JP 2022506944A5
- Authority
- JP
- Japan
- Prior art keywords
- dutasteride
- finasteride
- oil
- solution
- preservative
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024198983A JP2025032123A (ja) | 2018-11-08 | 2024-11-14 | ５－α－レダクターゼ阻害剤の局所製剤及びそれらの使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862757483P | 2018-11-08 | 2018-11-08 | |
| US62/757,483 | 2018-11-08 | ||
| US201962889318P | 2019-08-20 | 2019-08-20 | |
| US62/889,318 | 2019-08-20 | ||
| PCT/US2019/060194 WO2020097284A1 (en) | 2018-11-08 | 2019-11-07 | TOPICAL FORMULATIONS OF 5-α-REDUCTASE INHIBITORS AND USES THEREOF |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024198983A Division JP2025032123A (ja) | 2018-11-08 | 2024-11-14 | ５－α－レダクターゼ阻害剤の局所製剤及びそれらの使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022506944A JP2022506944A (ja) | 2022-01-17 |
| JP2022506944A5 true JP2022506944A5 (enExample) | 2022-11-15 |
Family
ID=70551490
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021525096A Pending JP2022506944A (ja) | 2018-11-08 | 2019-11-07 | ５－α－レダクターゼ阻害剤の局所製剤及びそれらの使用 |
| JP2024198983A Pending JP2025032123A (ja) | 2018-11-08 | 2024-11-14 | ５－α－レダクターゼ阻害剤の局所製剤及びそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024198983A Pending JP2025032123A (ja) | 2018-11-08 | 2024-11-14 | ５－α－レダクターゼ阻害剤の局所製剤及びそれらの使用 |
Country Status (4)
| Country | Link |
|---|---|
| US (2) | US11311529B2 (enExample) |
| EP (1) | EP3876935A4 (enExample) |
| JP (2) | JP2022506944A (enExample) |
| WO (1) | WO2020097284A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2882708A1 (en) | 2012-08-21 | 2014-02-27 | Sage Therapeutics, Inc. | Methods of treating epilepsy or status epilepticus |
| JOP20200195A1 (ar) | 2014-09-08 | 2017-06-16 | Sage Therapeutics Inc | سترويدات وتركيبات نشطة عصبياً، واستخداماتها |
| KR20240157128A (ko) | 2016-03-08 | 2024-10-31 | 세이지 테라퓨틱스, 인크. | 신경활성 스테로이드, 조성물, 및 그의 용도 |
| US11311529B2 (en) * | 2018-11-08 | 2022-04-26 | Varsona Therapeutics, Inc. | Topical formulations of 5-α-reductase inhibitors and uses thereof |
| WO2021225987A1 (en) * | 2020-05-02 | 2021-11-11 | XYON Health Inc. | Topical formulations comprising dutasteride for treating dermatological disorders including male pattern baldness |
| US11311556B2 (en) * | 2020-05-13 | 2022-04-26 | Varsona Therapeutics, Inc. | Topical dutasteride emulsions for treating endocrine therapy-induced alopecia |
| JP2023525160A (ja) | 2020-05-13 | 2023-06-14 | フォリクル・ファーマ・リミテッド | 毛包内への生物活性剤の送達のための組成物 |
| US11850300B2 (en) | 2022-03-17 | 2023-12-26 | Rally Guide | Topical lotion composition, methods of use, and methods of preparation |
| WO2025163683A1 (en) * | 2024-02-02 | 2025-08-07 | Zydus Lifesciences Limited | Pharmaceutical compositions of 5-alpha reductase inhibitors |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4299826A (en) * | 1979-10-12 | 1981-11-10 | The Procter & Gamble Company | Anti-acne composition |
| JPS5682843A (en) * | 1979-12-08 | 1981-07-06 | Nippon Oil Co Ltd | Wax emulsion |
| US4950475A (en) * | 1988-07-19 | 1990-08-21 | Imaginative Research Associates, Inc. | Novel film-forming gels with high concentrations of humectants and emollients |
| US5030374A (en) * | 1989-07-17 | 1991-07-09 | International Research And Development Corporation | Clear neutral non-foaming rapidly-rinsable gel facial cleanser formulation |
| US5422361A (en) * | 1989-12-20 | 1995-06-06 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| ZA954599B (en) * | 1994-06-07 | 1996-01-26 | Allergan Inc | Stable gel formulation for topical treatment of skin conditions |
| US7074747B1 (en) | 1999-07-01 | 2006-07-11 | Johnson & Johnson Consumer Companies, Inc. | Cleansing compositions |
| US20020035070A1 (en) | 2000-07-26 | 2002-03-21 | The Procter & Gamble Company | Method of regulating hair growth using metal complexes of oxidized carbohydrates |
| US6730641B2 (en) * | 2002-03-26 | 2004-05-04 | Alberto-Culver Company | Hair conditioning composition |
| US20070292355A1 (en) | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
| ATE534373T1 (de) * | 2003-10-10 | 2011-12-15 | Antares Pharma Ipl Ag | Transdermale pharmazeutische formulierung zur minimierung von rückständen auf der haut |
| US7854940B2 (en) * | 2004-09-16 | 2010-12-21 | Arch Chemicals, Inc. | Broad spectrum preservation blends |
| WO2006099121A2 (en) | 2005-03-10 | 2006-09-21 | Elan Pharma International Limited | Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof |
| WO2007046097A2 (en) | 2005-10-21 | 2007-04-26 | Medidermis Ltd. | Topical compositions for the treatment of depilation-induced skin irritation or prevention thereof |
| US8367112B2 (en) | 2006-02-28 | 2013-02-05 | Alkermes Pharma Ireland Limited | Nanoparticulate carverdilol formulations |
| WO2009072007A2 (en) | 2007-12-07 | 2009-06-11 | Foamix Ltd. | Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof |
| US20100048598A1 (en) * | 2008-08-21 | 2010-02-25 | Sateesh Kandavilli | Topical compositions comprising 5-alpha reductase inhibitors |
| CA2737025C (en) * | 2008-09-27 | 2012-09-04 | Jina Pharmaceuticals, Inc. | Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| EP2640398A4 (en) * | 2010-11-18 | 2014-05-14 | White Mountain Pharma Inc | METHOD FOR TREATING CHRONIC OR BZW. NON-RELIABLE PAIN AND / OR INCREASE OF PATIENT PAIN THRESHOLD AND PHARMACEUTICAL COMPOSITION FOR USE THEREOF |
| AU2011338530B2 (en) | 2010-12-06 | 2017-06-15 | Follica, Inc. | Methods for treating baldness and promoting hair growth |
| WO2012135337A2 (en) | 2011-03-28 | 2012-10-04 | Mary Kay Inc. | Topical skin care formulations comprising plant extracts |
| WO2013078259A2 (en) | 2011-11-25 | 2013-05-30 | Jackson Adrianna Janell | Oil compositions and methods for increasing hair growth and/or preventing hair loss |
| KR101976137B1 (ko) * | 2012-01-25 | 2019-05-09 | 한미약품 주식회사 | 두타스테라이드 함유 자가 유화 약물전달 시스템용 조성물 및 이의 제조 방법 |
| BR102012022036B1 (pt) | 2012-08-31 | 2019-10-01 | Biolab Sanus Farmacêutica Ltda. | Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso |
| US10441567B2 (en) | 2014-01-17 | 2019-10-15 | Ligand Pharmaceuticals Incorporated | Methods and compositions for modulating hormone levels |
| US11260013B2 (en) | 2016-07-15 | 2022-03-01 | Medicell Technologies, Llc | Compositions and methods for providing hair growth |
| ES2985673T3 (es) | 2017-07-11 | 2024-11-06 | Shilpa Medicare Ltd | Composiciones tópicas de dutasterida |
| US11311529B2 (en) * | 2018-11-08 | 2022-04-26 | Varsona Therapeutics, Inc. | Topical formulations of 5-α-reductase inhibitors and uses thereof |
| US11311556B2 (en) | 2020-05-13 | 2022-04-26 | Varsona Therapeutics, Inc. | Topical dutasteride emulsions for treating endocrine therapy-induced alopecia |
-
2019
- 2019-11-07 US US16/676,657 patent/US11311529B2/en active Active
- 2019-11-07 WO PCT/US2019/060194 patent/WO2020097284A1/en not_active Ceased
- 2019-11-07 EP EP19882117.5A patent/EP3876935A4/en active Pending
- 2019-11-07 JP JP2021525096A patent/JP2022506944A/ja active Pending
-
2022
- 2022-03-31 US US17/709,710 patent/US20230021330A1/en active Pending
-
2024
- 2024-11-14 JP JP2024198983A patent/JP2025032123A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022506944A5 (enExample) | ||
| ES2536933T3 (es) | Sistema de gel polifásico libre de agua | |
| KR101769637B1 (ko) | 모발 성장을 촉진하기 위한 조성물 및 방법 | |
| US11311529B2 (en) | Topical formulations of 5-α-reductase inhibitors and uses thereof | |
| KR20150129733A (ko) | 비마토프로스트를 포함하는 국소 조성물 및 이를 사용하여 모발 성장을 자극하는 방법 | |
| JPH0148885B2 (enExample) | ||
| CA3198046A1 (en) | Compositions and methods for deep dermal drug delivery | |
| JP2023525160A (ja) | 毛包内への生物活性剤の送達のための組成物 | |
| JPH1192378A (ja) | 外用育毛液剤 | |
| AU2021368099A9 (en) | Methods for treating vitiligo lesions having improved efficacy | |
| JP2001064206A (ja) | 経皮吸収促進組成物 | |
| EP1404336A1 (en) | Compositions comprising cgmppde5 inhibitor for transdermal delivery to the erectile tissue of the penis | |
| HK40120043A (zh) | 毛发生长的刺激 | |
| CN115243684A (zh) | 毛发生长的刺激 | |
| AU2024349089A1 (en) | Novel topical pharmaceutical composition for prevention and treatment of hair loss | |
| AU2012261730B2 (en) | Anhydrous multiphase gel system | |
| JP2026074274A (ja) | 外用医薬組成物 | |
| HK1116666A (en) | Anhydrous multiphase gel system | |
| HK1116666B (en) | Anhydrous multiphase gel system | |
| JP2002114645A (ja) | 養毛料 | |
| HK1174270B (en) | Compositions and methods for stimulating hair growth | |
| HK1174270A (en) | Compositions and methods for stimulating hair growth |